Table 2 Results of cultivation and multiplex PCR identification of Campylobacter isolates



<table><tr><td>Cultivation</td><td colspan="4">mPCR identification of Campylobacter</td><td rowspan="2">Total n (%)</td></tr><tr><td></td><td>C. jejuni</td><td>C. coli</td><td>Not identified</td><td>C. coli/C. jejuni</td></tr><tr><td>Positive (n)</td><td>31</td><td>4</td><td>5</td><td>0</td><td>40 (69.0)</td></tr><tr><td>Negative (n)</td><td>3</td><td>14</td><td>0</td><td>1</td><td>18 (31.0)</td></tr></table>

(MAMA–PCR) was used to characterize a gyrA gene mutation associated with ciprofloxacin resistance as well as mutations in 23S rRNA genes as cause of erythromycin resistance. The molecular biological detection of resistance to ciprofloxacin in both C. coli and C. jejuni was also confirmed by change of amino acid 86 from threonine to isoleucine in the gyrA gene. Additional to the ciprofloxacin resistant Campylobacter isolates (Tables 3, 4), three Campylobacter DNAs were detected harbouring the gyrA gene mutation. The results were confirmed by PCR–RFLP according to Vacher et al. [24]. Mutations at positions 2074 and 2075 of the 23S rRNA genes in 13 phenotypically erythromycin-resistant isolates could neither be detected by using PCR–RFLP nor MAMA–PCR.



The  $ tet(O) $  gene which is mainly responsible for tetracycline-resistance was detected by PCR in 12 out of 22 resistant C. jejuni isolates (54.5 %) and in all tetracycline resistant C. coli isolates.  $ tet(O) $  gene was not detected in DNA extracted from the non-growing samples. Additionally, a newly developed PCR assay was used for the detection of the  $ tet(A) $  gene.  $ tet(A) $  was detected in 28 out of 31 C. jejuni (90.3 %) and in all 4 C. coli isolates. In 3 out of 14 non-growing samples which harboured C. coli DNA,  $ tet(A) $  gene could be found as well as in the one sample where both C. jejuni and C. coli were detected.

Table 3 Results of MIC determination and resistance rates of Kenyan Campylobacter jejuni isolates



<table><tr><td rowspan="2">Class</td><td rowspan="2">Antibiotic ( $ \mu $ g/ml)</td><td colspan="12">Antibiotic susceptibility of Campylobacter jejuni (n=31)</td><td rowspan="9">R $ ^{*} $  (%)</td></tr><tr><td>0.06</td><td>0.12</td><td>0.25</td><td>0.5</td><td>1</td><td>2</td><td>4</td><td>8</td><td>16</td><td>32</td><td>64</td><td></td></tr><tr><td rowspan="2">Macrolides</td><td>Chloramphenicol</td><td></td><td></td><td></td><td></td><td></td><td>9</td><td>3</td><td>6</td><td>5</td><td>8</td><td></td><td>25.8</td></tr><tr><td>Erythromycin</td><td></td><td></td><td></td><td>14</td><td></td><td></td><td>1</td><td>2</td><td>2</td><td>12</td><td></td><td>51.6</td></tr><tr><td>Fluoroquinolones</td><td>Ciprofloxacin</td><td>5</td><td>2</td><td>2</td><td></td><td>2</td><td>1</td><td>19</td><td></td><td></td><td></td><td></td><td>71.0</td></tr><tr><td>Quinolones</td><td>Nalidixic acid</td><td></td><td></td><td></td><td></td><td></td><td></td><td>4</td><td>1</td><td>2</td><td>2</td><td>22</td><td>77.4</td></tr><tr><td rowspan="2">Aminoglycosides</td><td>Gentamicin</td><td></td><td>2</td><td>1</td><td>4</td><td>11</td><td>5</td><td>2</td><td>1</td><td>5</td><td></td><td></td><td>25.8</td></tr><tr><td>Streptomycin</td><td></td><td></td><td></td><td></td><td>12</td><td>2</td><td>4</td><td>1</td><td>12</td><td></td><td></td><td>41.9</td></tr><tr><td>Tetracyclines</td><td>Tetracycline</td><td></td><td></td><td>6</td><td>1</td><td>2</td><td></td><td>1</td><td>1</td><td>20</td><td></td><td></td><td>71.0</td></tr></table>

Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains  $ R^{*} $  resistance rate

Table 4 Results of MIC determination and resistance rates of Kenyan Campylobacter coli isolates



<table><tr><td rowspan="2">Class</td><td rowspan="2">Antibiotic ( $ \mu $ g/ml)</td><td colspan="12">Antibiotic susceptibility of Campylobacter coli (n=4)</td><td rowspan="4">R $ ^{*} $  (%)</td></tr><tr><td>0.06</td><td>0.12</td><td>0.25</td><td>0.5</td><td>1</td><td>2</td><td>4</td><td>8</td><td>16</td><td>32</td><td>64</td><td></td></tr><tr><td rowspan="2">Macrolides</td><td>Chloramphenicol</td><td></td><td></td><td></td><td></td><td></td><td>2</td><td></td><td></td><td></td><td>2</td><td></td><td>50.0</td></tr><tr><td>Erythromycin</td><td></td><td></td><td></td><td>4</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>0</td></tr><tr><td>Fluoroquinolones</td><td>Ciprofloxacin</td><td>1</td><td></td><td></td><td></td><td></td><td></td><td>3</td><td></td><td></td><td></td><td></td><td></td><td>75.0</td></tr><tr><td>Quinolones</td><td>Nalidixic acid</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>1</td><td></td><td></td><td></td><td>3</td><td>75.0</td></tr><tr><td rowspan="2">Aminoglycosides</td><td>Gentamicin</td><td></td><td>1</td><td></td><td>1</td><td>1</td><td></td><td>1</td><td></td><td></td><td></td><td></td><td></td><td>25.0</td></tr><tr><td>Streptomycin</td><td></td><td></td><td></td><td></td><td>2</td><td></td><td>2</td><td></td><td></td><td></td><td></td><td></td><td>0</td></tr><tr><td>Tetracyclines</td><td>Tetracycline</td><td></td><td></td><td>1</td><td>1</td><td>1</td><td></td><td></td><td></td><td></td><td>1</td><td></td><td></td><td>25.0</td></tr></table>

Boldface in italic type indicates the number of resistant isolates. A thick black line indicates the break point between clinically sensitive and resistant strains  $ R^{*} $  resistance rate